Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00033709
Status:
UNKNOWN
Last Update Posted:
2014-01-06
First Post:
2002-04-09
Brief Title:
Temozolomide and Thalidomide in Treating Patients With Metastatic Locally Advanced or Unresectable Leiomyosarcoma
Sponsor:
Herbert Irving Comprehensive Cancer Center
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000069314
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Herbert Irving Comprehensive Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |